Live Feeds

Source map — Ozempic Rival Delivers 25% Weight Loss at Highest Dose in Phase 3 Trial

Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.

SourceTypeTrust
The Guardian news 60%
Scientific American news 60%
Eli Lilly news 60%
Reuters news 60%
USA Today news 60%
Fierce Biotech news 60%
WSJ news 60%
CNBC news 60%
ScienceAlert news 60%
vialaudit.com news 50%
frnt.com news 50%
glp1watchdog.com news 50%
scitechdaily.com news 50%
puripharmacy.co.uk news 50%
www.aestheticsadvisor.com news 50%
medicalxpress.com news 50%
www.diabetes.co.uk news 50%
therxindex.com social 50%
peptidechecked.com news 50%
pharmaphorum.com news 50%
www.healthcount.app news 50%
www.news-age.com news 50%
www.onedaymd.com news 50%
theclinicaltimes.com news 50%
www.cerritosnewspaper.com news 50%
shotlee.app news 50%
www.dazzr.com news 50%
www.glp3.wiki news 50%
www.medicaldaily.com news 50%
www.sciencealert.com news 50%